• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA S.R.L. - CRM FACILITY REPLY; PULSE GENERATOR, PERMANENT, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA S.R.L. - CRM FACILITY REPLY; PULSE GENERATOR, PERMANENT, IMPLANTABLE Back to Search Results
Model Number REPLY D
Device Problems Failure to Capture (1081); Over-Sensing (1438); Unstable Capture Threshold (3269)
Patient Problem Fainting (1847)
Event Date 08/22/2019
Event Type  malfunction  
Manufacturer Narrative
The device model involved in this mdr is not approved in the united states; however, it is similar to a device manufactured by sorin that was cleared or approved by fda for marketing in the united states.
 
Event Description
Reportedly, the patient was hospitalized because he fainted.Upon pacemaker interrogation, the physician observed several episodes showing noise oversensing and intermittent loss of capture was noted on an ecg.Tests were performed and the threshold was measured at 1 ¿ 1.25 v / 0.6 ms.The ventricular waves were measured at 5 mv.Preliminary analysis revealed that the ventricular noise oversensing and loss of ventricular capture most probably resulted from a ventricular lead issue and/or a lead-pacemaker connection issue at ventricular level.
 
Event Description
Reportedly, the patient was hospitalized because he fainted.Upon pacemaker interrogation, the physician observed several episodes showing noise oversensing and intermittent loss of capture was noted on an ecg.Tests were performed and the threshold was measured at 1 ¿ 1.25 v / 0.6 ms.The ventricular waves were measured at 5 mv.Preliminary analysis revealed that the ventricular noise oversensing and loss of ventricular capture most probably resulted from a ventricular lead issue and/or a lead-pacemaker connection issue at ventricular level.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REPLY
Type of Device
PULSE GENERATOR, PERMANENT, IMPLANTABLE
Manufacturer (Section D)
SORIN GROUP ITALIA S.R.L. - CRM FACILITY
parc d'affaires noveos 4 avenue réaumur
.
clamart 92140
FR  92140
MDR Report Key8995095
MDR Text Key160162744
Report Number1000165971-2019-00537
Device Sequence Number1
Product Code NVZ
UDI-Device Identifier08031527008998
UDI-Public(01)08031527008998(11)190325(17)201025
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 12/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/25/2020
Device Model NumberREPLY D
Device Catalogue NumberREPLY D
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date08/22/2019
Initial Date Manufacturer Received 08/22/2019
Initial Date FDA Received09/11/2019
Supplement Dates Manufacturer Received11/22/2019
Supplement Dates FDA Received12/10/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-